Ligand validation:6S0W

9CS: (1R,2S,3S,4R,6S)-4,6-DIAMINO-3-[(3-AMINO-3-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSIDE

9CS is a Ligand Of Interest in 6S0W designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6S0W_9CS_F_301	30%	70%	0.227	0.89	0.51	0.63	1	-	0	0	100%	0.7
6S0W_9CS_D_301	20%	75%	0.223	0.826	0.43	0.54	-	-	1	0	100%	0.8576
6S0W_9CS_C_301	10%	67%	0.276	0.783	0.49	0.76	-	-	0	0	100%	0.8
6S0W_9CS_E_301	6%	68%	0.3	0.734	0.43	0.77	-	-	0	0	100%	0.7
6S0W_9CS_B_301	4%	71%	0.347	0.734	0.36	0.74	-	1	2	0	100%	0.6
6S0W_9CS_A_301	1%	72%	0.568	0.755	0.34	0.7	-	-	0	0	100%	0.6
7CL5_9CS_D_303	80%	50%	0.127	0.978	0.86	1.07	1	2	0	0	100%	1
7CL3_9CS_C_303	67%	49%	0.136	0.946	0.93	1.04	1	2	0	0	100%	1
7UUL_9CS_C_301	85%	36%	0.092	0.959	1.44	1.15	5	3	0	0	100%	1
5U1E_9CS_A_401	67%	32%	0.119	0.928	1.56	1.24	5	6	0	0	100%	1
2QIR_9CS_A_501	33%	47%	0.188	0.867	0.98	1.08	2	3	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.